BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21072752)

  • 21. Noninvasive fetal RhD genotyping.
    Clausen FB; Damkjær MB; Dziegiel MH
    Transfus Apher Sci; 2014 Apr; 50(2):154-62. PubMed ID: 24642067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of RHD by real-time polymerase chain reaction for determination of RHD zygosity and RHD mosaicism/chimerism: an evaluation of four quantitative methods.
    Krog GR; Clausen FB; Dziegiel MH
    Transfusion; 2007 Apr; 47(4):715-22. PubMed ID: 17381631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal blood group genotyping.
    Denomme GA; Fernandes BJ
    Transfusion; 2007 Jul; 47(1 Suppl):64S-8S. PubMed ID: 17593289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
    Daniels G; Finning K; Martin P; Summers J
    Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].
    Cortey A; Brossard Y; Beliard R; Bourel D
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S119-1S122. PubMed ID: 16495837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.
    Bianchi DW; Avent ND; Costa JM; van der Schoot CE
    Obstet Gynecol; 2005 Oct; 106(4):841-4. PubMed ID: 16199645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in the reliability of RHD antenatal genotyping using the polymerase chain reaction and targeting multiple exons of the RHD gene.
    Johnson L; McCracken SA; Morris JM; Woodland NB; Flower RL
    Vox Sang; 2003 Oct; 85(3):222-3. PubMed ID: 14516455
    [No Abstract]   [Full Text] [Related]  

  • 29. Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects.
    Daniels G; Finning K; Martin P; Massey E
    Prenat Diagn; 2009 Feb; 29(2):101-7. PubMed ID: 19085963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal determination of fetal RhD (rhesus positive) type by an amplification of DNA.
    Kvasnicka J; Rypácková B; Calda P; Hájek Z
    Sb Lek; 1998; 99(1):13-20. PubMed ID: 9748794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antenatal
    Clausen FB
    Immunohematology; 2024 Apr; 40(1):15-27. PubMed ID: 38739027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive blood group genetics in hemolytic disease of the fetus and newborn: a 10-year review of a laboratory evaluation of amniotic fluid-derived DNA.
    Seto E; Fernandes BJ; Wang C; Denomme GA
    Prenat Diagn; 2007 Nov; 27(11):1017-23. PubMed ID: 17705237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

  • 35. The new and the old--molecular diagnostics and hemolytic disease of the newborn.
    Luban NL
    N Engl J Med; 1993 Aug; 329(9):658-60. PubMed ID: 8341343
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemolytic disease of the newborn caused by anti-D with factor Du in the mother].
    Brandstädter W; Brandstädter M
    Zentralbl Gynakol; 1970 Feb; 92(6):176-8. PubMed ID: 5001845
    [No Abstract]   [Full Text] [Related]  

  • 37. A curious case of anti-D antibody titer.
    Hensley JG; Coughlin KP; Klein LL
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antenatal serologic assessment of severity of hemolytic disease due to anti-Rh.
    Frankowska K
    Arch Immunol Ther Exp (Warsz); 1971; 19(5):613-9. PubMed ID: 5006484
    [No Abstract]   [Full Text] [Related]  

  • 39. Early detection of RhD status in pregnancies at risk of hemolytic disease of the newborn.
    Cotorruelo C; Biondi C; García Borrás S; Di Mónaco R; Racca A
    Clin Exp Med; 2002 Jul; 2(2):77-81. PubMed ID: 12141530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis.
    Zhu YJ; Zheng YR; Li L; Zhou H; Liao X; Guo JX; Yi P
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1839-44. PubMed ID: 24422551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.